Neurotech International Ltd. (AU:NTI) has released an update.
Biotech Capital Management Pty Ltd has emerged as a substantial shareholder in Neurotech International Limited, securing a 5.4% stake with 54,987,203 ordinary shares. This financial move was solidified on 13 September 2024, marking a significant change in the investment landscape for the biotechnology firm. The intricate web of associated entities and their shared interests underscores the complexity of this major investment shift.
For further insights into AU:NTI stock, check out TipRanks’ Stock Analysis page.
